undefined undefined
NaN.000
NaN.00%
Gainers: Masimo (MASI) +12%. Pliant Therapeutics (PLRX) +5%. Vor Biopharma (VOR) +5%. Vor Biopharma (CNDT) +4%. Xometry (XMTR) +4%. Losers: Airship AI Holdings (AISP) -7%. Canopy Growth (CGC) -4%. Cal...
03-23 04:59
Some say volatility, rather than debt, is the best way to think about risk as a...
03-06 18:10
吴晨 新时期背景下,城市的发展需求对规划建设提出了更高要求。相应地,营城思想与规划思想也应在适应新需求的过程中不断演进和跃升,探寻更可持续的道路。 ...
03-01 03:35
成分股Exscientia ADR收跌22.84%,Taysha Gene、 杰龙(GERN)、Pliant、Ovid Therapeutics、NantKw...
02-14 05:35
当地时间2024年2月5日,美股三大指数集体收跌,纳指跌0.2%,标普500指数跌0.32%,道指跌0.71%。美股创新药板块方面,纳斯达克生物科技指数(NB...
02-06 15:51
Immunovant正在开发抗体药物IMVT-1402,小摩表示,若该药物在后续研究中取得成功,或将为同类药物中最好的;Intercept制药隔夜上涨超79%,同意以每股19美元的价格被收购>>
2023-09-27 15:11
Pliant Therapeutics(PLRX.US)宣布,在研疗法bexotegrast在治疗原发性硬化性胆管炎(PSC)并疑似中度至重度肝纤维化患者的2a期临床试验中达到主要和次要终点。
2023-09-27 09:51
During the session on Thursday, 461 stocks hit new 52-week lows.
2023-09-22 00:08
Analysts have provided the following ratings for Pliant Therapeutics (NASDAQ:PL...
2023-08-23 04:00
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0.71) by 1.41 percent. This is a 4.48 percent decrease over losses of $(0.67) per share from
2023-08-10 04:52